John Libbey Eurotext

European Journal of Dermatology

MENU

Pemphigus foliaceous after mRNA COVID-19 vaccine Volume 32, numéro 3, May-June 2022

Illustrations

  • Figure 1.
Auteurs
1 Department of Dermatology, Centro Hospitalar Universitário do Porto, Porto, Portugal
2 Department of Immunology, Centro Hospitalar Universitário do Porto, Porto, Portugal
3 Department of Pathology, Centro Hospitalar Universitário do Porto, Porto, Portugal

Pemphigus foliaceous (PF) is a rare autoimmune bullous disorder. The key target is desmoglein 1 (Dsg1), an important component of desmosomes along with Dsg3, which holds keratinocytes within the epithelium [1]. Genetic susceptibility, drugs, malignant disorders, ultraviolet light, and stress have been reported to trigger or exacerbate PF. Here, we report the case of a patient who developed PF following COVID-19 vaccination with the mRNA vaccine, BNT162b2 (Comirnaty, Biontech/Pfizer).A 35-year-old [...]